Literature DB >> 11598041

Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.

J S Brown1, A D Ogunniyi, M C Woodrow, D W Holden, J C Paton.   

Abstract

There has been considerable recent research into protein based Streptococcus pneumoniae vaccines as alternatives to the existing capsular antigen vaccines. PiuA and PiaA (formerly Pit1A and Pit2A) are recently identified lipoprotein components of S. pneumoniae iron uptake ABC transporters which are required for full virulence and are likely to be expressed on the surface of the bacterial cell membrane. We investigated the efficacy of recombinant PiuA and PiaA proteins at eliciting protective immunity in mice against systemic infection with S. pneumoniae. Both recombinant PiuA and PiaA generated antibody responses that cross-reacted with each other but not with pneumolysin and reacted with identical proteins from nine different S. pneumoniae serotypes. Mice immunized with recombinant PiuA and PiaA were protected against systemic challenge to a degree similar to those immunized with an existing protein vaccine candidate, PdB (a genetically modified pneumolysin toxoid). Immunization with a combination of both PiuA and PiaA resulted in additive protection and was highly protective against systemic infection with S. pneumoniae. PiuA and PiaA are therefore promising additional candidates for a novel S. pneumoniae vaccine using protein antigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598041      PMCID: PMC100046          DOI: 10.1128/IAI.69.11.6702-6706.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Authors:  A H Tu; R L Fulgham; M A McCrory; D E Briles; A J Szalai
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  A Streptococcus pneumoniae pathogenicity island encoding an ABC transporter involved in iron uptake and virulence.

Authors:  J S Brown; S M Gilliland; D W Holden
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

Review 3.  Prospects for pneumococcal vaccination in African children.

Authors:  S K Obaro
Journal:  Acta Trop       Date:  2000-03-25       Impact factor: 3.112

4.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

5.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

6.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

Authors:  H Y Wu; M H Nahm; Y Guo; M W Russell; D E Briles
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

7.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.

Authors:  J B Rubins; D Charboneau; J C Paton; T J Mitchell; P W Andrew; E N Janoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 9.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

10.  Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.

Authors:  R C Tart; L S McDaniel; B A Ralph; D E Briles
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

View more
  67 in total

1.  Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.

Authors:  Avi-Hai Hovav; Liuba Davidovitch; Gabriel Nussbaum; Jacob Mullerad; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

2.  phgABC, a three-gene operon required for growth of Streptococcus pneumoniae in hyperosmotic medium and in vivo.

Authors:  Jeremy S Brown; Sarah M Gilliland; Shilpa Basavanna; David W Holden
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

3.  Impact of glutamine transporters on pneumococcal fitness under infection-related conditions.

Authors:  Tobias Härtel; Matthias Klein; Uwe Koedel; Manfred Rohde; Lothar Petruschka; Sven Hammerschmidt
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

4.  Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.

Authors:  Abiodun D Ogunniyi; Layla K Mahdi; Claudia Trappetti; Nadine Verhoeven; Daphne Mermans; Mark B Van der Hoek; Charles D Plumptre; James C Paton
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 5.  ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies.

Authors:  Helen S Garmory; Richard W Titball
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 6.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

7.  LuxS mediates iron-dependent biofilm formation, competence, and fratricide in Streptococcus pneumoniae.

Authors:  Claudia Trappetti; Adam J Potter; Adrienne W Paton; Marco R Oggioni; James C Paton
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

8.  Characterization of a Bacillus subtilis transporter for petrobactin, an anthrax stealth siderophore.

Authors:  Anna M Zawadzka; Youngchang Kim; Natalia Maltseva; Rita Nichiporuk; Yao Fan; Andrzej Joachimiak; Kenneth N Raymond
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

Review 9.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  A 38-kilobase pathogenicity island specific for Mycobacterium avium subsp. paratuberculosis encodes cell surface proteins expressed in the host.

Authors:  Janin Stratmann; Birgit Strommenger; Ralph Goethe; Karen Dohmann; Gerald-F Gerlach; Karen Stevenson; Ling-Ling Li; Qing Zhang; Vivek Kapur; Tim J Bull
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.